Abstract Our aim was to shed light on different steps leading from metabotropic receptor activation to changes in cell shape, such as those that characterize the morphological plasticity of neurohypophysial astrocytes (pituicytes). Using explant cultures of adult rat pituicytes, we have previously established that adenosine A1 receptor activation induces stellation via inhibition of RhoA monomeric GTPase and subsequent disruption of actin stress fibers. Here, we rule out RhoA phosphorylation as a mechanism for that inhibition. Rather, our results are more consistent with involvement of a GTPase-activating protein (GAP). siRNA and pull-down experiments suggest that a step downstream of RhoA might involve Cdc42, another GTPase of the Rho family. However, RhoA activation, e.g., in the presence of serum, induces stress fibers, whereas direct Cdc42 activation appears to confine actin within a submembrane-i.e., cortical-network, which also prevents stellation. Therefore, we propose that RhoA may activate Cdc42 in parallel with an effector, such as p160Rho-kinase, that induces and maintains actin stress fibers in a dominant fashion. Rac1 is not involved in the stellation process per se but appears to induce a dendritogenic effect. Ultimately, it may be stated that pituicyte stellation is inducible upon mere actin depolymerization,
and preventable upon actin organization, be it in the form of stress fibers or in a cortical configuration.
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Introduction
In recent years, considerable attention has been given to the morphofunctional plasticity of glial cells as an important means of maintaining homeostasis in the nervous system. The hypothalamus-neurohypophysis system represents an example where such a plasticity may have direct physiological significance. For instance, during relevant stimulations, such as dehydration or lactation, astrocytes of the posterior pituitary (pituicytes) retract from perivascular spaces, thereby increasing access of secreting terminals to the basal lamina, and facilitating release of vasopressin (VP) or oxytocin into the blood (reviewed in Theodosis and MacVicar 1996; Hatton 1999) .
Our previous in vitro studies showed that the morphological plasticity of pituicytes can be controlled via specific membrane receptors of the G-protein-coupled receptor (GPCR) family, and downstream regulation of RhoA and Cdc42 GTPase activity (Rosso et al. 2002a, b) . In culture conditions, pituicytes exhibit a flat, spread shape due to serum components (e.g., lysophosphatidic acid; LPA) that are powerful RhoA activators (Ramakers and Moolenaar 1998) . Spreading is maintained in serum concentrations as low as 0.025%, a condition that in turn allows induction of stellation by adenosine A1 receptor activation and reversible inhibition of RhoA. Stellation can also be induced by C3 toxin, an irreversible RhoA inhibitor, and by Y-27632, an inhibitor of the RhoA effector p160Rho-kinase. Stellation induced by adenosine, C3 toxin or Y-27632 can be reversed-i.e., spreading can be restored-by subnanomolar concentrations of the neurohormone VP acting at V1a receptors. These findings have physiological relevance because (1) adenosine is readily generated from breakdown of ATP, which is present in VP secretory vesicles (Gratzl et al. 1980) , (2) exocytosis of these vesicles occurs locally from axon swellings, i.e. in the pituicyte environment (Morris et al. 1988) , and (3) pituicyte shape in turn is likely to influence neurohormone output (Theodosis and MacVicar 1996; Hatton 1999) .
The fact that VP reverses stellation induced by the irreversible RhoA inhibitor C3 argued against a RhoA-dependent effect of the hormone. Indeed, our pull-down assays showed no increase of activated RhoA in the presence of VP. Instead, consistent with our previous observation that VP induces the formation of short membrane protrusions resembling filopodia, a process known to be under the control of Cdc42 (Hall 1998) , we have found that VP reverses stellation through Cdc42 activation. Thus, in pull-down assays VP increases the amount of activated Cdc42, and VP-mediated reversal of stellation is blocked by transfection of NWASP-GBD, the GTPase binding domain of a Wiscott-Aldrich syndrome-related protein that blocks endogenous Cdc42 (Rosso et al. 2002b) . As RhoA inhibition alone is sufficient to induce stellation, our initial hypothesis was that in ''resting'' conditions (e.g., 0.025% serum) Cdc42 is inactive, or at least is not active enough to induce spreading. However, another possible interpretation is that RhoA and Cdc42 are functionally linked. For instance, it has been suggested that RhoA can act downstream of Cdc42 (Hall 1998) . This scheme, nevertheless, is highly unlikely in pituicytes as Cdc42 activation by VP (1) reverses C3-induced stellation (whereas LPA fails to do so), and (2) does not change the level of activated RhoA as measured in pulldown assays (whereas LPA does). The converse possibility that RhoA may activate Cdc42 was not examined in our previous work. Here, we used small-interfering (si) RNA and mutant GTPase expression techniques in order to expand our understanding of the respective roles of RhoA and Cdc42 in pituicyte shape changes. Additional objectives were (i) to gain further insight into the mechanism of RhoA inhibition by adenosine; (ii) to investigate any potential role of Rac1, another monomeric GTPase involved in cell morphology; and ultimately (iii) to identify the cytoskeletal targets that transduce the observed plasticity of pituicytes.
Materials and Methods

Pituicyte Cultures and Morphological Analysis
Pituicyte explant cultures were prepared as described previously (Rosso et al. 2002a ) from adult Wistar rats (150-200 g) anesthetized with pentobarbital (55 lg g -1
) and decapitated in accordance with French/European ethical guidelines. We used 8-12-dayold cultures plated on collagen-coated Petri dishes. Due to the inhibitory effect of serum on stellation, cells were switched to a low-serum (0.025%) medium one hour prior to experiments, a standard procedure followed by most authors (e.g., Ramsell and Cobbett 1997; Abe and Saito 1998) . All drugs or their vehicle as control were added one hour (37°C) prior to phase-contrast image acquisition. The latter was performed with a digital still camera and Adobe Photoshop software was used for cell counting. Digitized images were coded with respect to treatment in order to perform blind counting. Cells were considered as stellate when they displayed phase-bright somas with two or more processes at least 2 soma diameters long (Narumi et al. 1978) . For each culture dish, relative stellation (number of stellate/total cells in field · 100) was assessed by counting 100-200 cells at 10· magnification over 5 arbitrarily chosen areas 0.9 · 0.7 mm wide, and taking the resulting average.
siRNA Transfection
RhoA and Cdc42 siRNAs (for sequences see Deroanne et al. 2005 , the ''first'' siCdc42 sequence was used in the present study) were purchased from Eurogentec (Serang, Belgium) and transfected into cells grown in regular (10%) serum medium using a Ca 2+ phosphate protocol as described previously (Vouret-Craviari et al. 2004) . Cells were analyzed 48 h after the second transfection. The efficiency of protein silencing was assessed by western blot using specific antibodies obtained from Santa Cruz Biotechnology (mouse anti-RhoA), Transduction Laboratories (mouse anti-Cdc42), or Sigma (mouse anti-a smooth muscle actin). Blots were analyzed with ScionImage software to perform light intensity quantification over bands of interest. Relative light intensity was then normalized and is expressed as the ratio of GTPase signal intensity divided by corresponding actin signal intensity.
DNA Constructs
RhoA-S188A and S188D (see supplemental data in Rolli-Derkinderen et al. 2005 , for primers used in mutagenesis), cloned in the pKH3-HA vector, were provided to us by G.
Loirand (INSERM U533, Nantes, France). RhoA-G14V, cloned in the pSG5 vector, was given to us by P. Chardin (CNRS UMR 6097, Nice, France). The GFP fusion proteins of Cdc42-V12 and Rac1, cloned in the pEGFP-C1 vector (Roux et al. 1997; Gadea et al. 2002) , were provided by P. Roux (CNRS FRE 2593, Montpellier, France) .
Transfection, Retroviral Infection and Fluorescence Labeling
In order to monitor the morphological effects of RhoA mutants, we used a modified version of the GFP reporter method (Fincham et al. 1999) ; using the Ca 2+ phosphate method, pituicytes were transfected with either GFP alone (pEGFP plasmid, Clontech) as control or cotransfected with GFP and RhoA mutants at a 1:10 concentration ratio. Regarding Cdc42 and Rac1 experiments, we have transduced pituicytes as follows: retroviral packaging HEK-293 Phoenix cells were transfected using a modified Ca 2+ phosphate protocol in the presence of 25 mM chloroquine. The next day, the medium was replaced with fresh growth medium. After 48 h, conditioned medium was harvested, filtered through a 0.45-lm filter, and polybrene was added to a final concentration of 4 lg/ ml. For infection, pituicytes were trypsinized 4 h before the addition of the viral supernatant. After exposure to specific control and test conditions as indicated, the cells were fixed with 3% paraformaldehyde +2% sucrose at 37°C, washed 3 times in PBS, permeabilized for 4 min in PBS +0.2% Triton, and again rinsed 3 times in PBS and saturated 15 min in PBS +5% serum. Actin was labeled with rhodamine-or fluoresceinconjugated phalloidin. Pituicytes transfected or transduced with the different vectors and/ or labeled with phalloidin were mounted on slides in the presence of Citifluor for observation on an epifluorescence microscope at appropriate wavelengths.
Cdc42 Activity Assay
Pull-down assays were performed using bacterially produced GST-CRIB (Cdc42/Rac interactive binding domain from PAK) as described previously (Rosso et al. 2002a, b) on five 60-mm culture dishes per experimental condition (see details in Results). Levels of activated and total Cdc42 were determined by Western blotting (monoclonal antiCdc42 # C70820, Transduction Laboratories) and used to quantify GTPase activation by densitometric analysis. The optical density of each band on the blot was analyzed with PCBAS software (Raytest, Straubenhardt, Germany) and, after background subtraction, the ratio of activated/total GTPase was calculated.
Drugs
Adenosine, phalloidin-TRITC or FITC, cytochalasin D, calyculin-A, and vasopressin were purchased from Sigma. Jasplakinolide was from Calbiochem.
Results
Effects of Monomeric GTPase Expression on Pituicyte Morphology
In order to gain insight into the role of RhoA and Cdc42 in pituicyte morphology, we used a loss of function approach to silence expression of each protein. Transfection of pituicytes with RhoA or Cdc42 siRNA duplexes resulted in a substantial decrease (~70 or 80% respectively), but not complete disappearance of protein expression (Fig. 1) . Transfected cells were analyzed for their morphological features, which revealed a moderate tendency for stellation in both RhoA-and Cdc42-depleted cells, as compared to control cells (Fig. 2) . The key finding of these experiments is that Cdc42 silencing results in significant stellation indicating, contrary to our initial assumption, that the GTPase is somewhat active in basal conditions. This in turn suggests a functional link between RhoA and Cdc42, given the fact that RhoA inhibition per se induces stellation. As mentioned earlier, a control of Cdc42 over RhoA is highly unlikely; thus, we here tested the alternative possibility that Cdc42 acts downstream of RhoA. For that purpose, we performed a Cdc42 pull-down in conditions of RhoA inhibition by 10 lM adenosine versus its full activation by 10% serum (see Rosso et al. 2002a ). For comparison, we included Cdc42 activity measurements during 5 or 10-min exposures to 10 nM VP, which we previously showed to be a reliable Cdc42 activator (Rosso et al. 2002b ). The results indicate that Cdc42 activity in serum is comparable to that obtained with VP, and higher than that in the presence of adenosine (Fig. 3) , i.e. in conditions of RhoA inhibition. Although we cannot exclude the possibility of a direct effect of serum on Cdc42, an interpretation consistent with our siRNA results is that Cdc42 activation is due to RhoA stimulation.
In order to confirm the major role of RhoA in pituicyte stellation and gain further insight into the mechanism involved, we transfected cells with GFP either alone or in combination with RhoA-G14V, a constitutively active mutant of the GTPase. GFP transfection did not induce any effect in pituicytes, which maintained their spread shape in control conditions, and became stellate in the presence of 10 lM adenosine (Fig. 4 , # p = 0.001 (n = 4 each) compared to control (without); Student's one-tail t-test upper panels). This rules out non-specific effects of the transfection procedure on pituicyte morphology. Likewise, cotransfection of GFP + RhoA-G14V did not affect spread pituicytes (Fig. 4, lower left panel) . On the other hand, RhoA-G14V expression clearly prevented adenosine from inducing pituicyte stellation (Fig. 4, lower Fig. 3 Pull-down of Cdc42 in various conditions as indicated. Upper panels show western blots of total and activated protein from pituicytes incubated in 0.025% serum with 10 lM adenosine (Ado) for 45 min, to which 10 nM VP was added for 5 or 10 min, or in 10% serum (no drug added). Lower panel shows the corresponding ratio of activated/total Cdc42 panel), consistent with our previous finding that adenosine induces stellation via RhoA inhibition. In order to determine whether the mechanism of inhibition involves serine phosphorylation of RhoA, as was shown in other cell types (Lang et al. 1996; Ellerbroek et al. 2003) , we transfected pituicytes with two types of mutants: RhoA-S188A, a phosphorylation-resistant mutant, or RhoA-S188D, a phosphomimetic mutant. The former had no effect on spread pituicytes nor did it prevent adenosine from inducing stellation, whereas the latter mutant by itself did not induce stellation (Fig. 5) . This suggests that adenosine induces pituicyte stellation by inhibiting RhoA via a mechanism other than phosphorylation.
We then investigated in more detail the role of Cdc42 in pituicyte morphology. For that purpose, we transduced cells with Cdc42-V12, a constitutively active mutant of the GTPase, fused to GFP. The expression of GFP alone did not prevent adenosine from inducing stellation, which is characterized by a diffuse staining of actin in both transfected and non-transfected cells (Fig. 6, upper panels) . Conversely, cells expressing Cdc42-V12 were resistant to adenosine-induced stellation, with actin rather organized as a submembrane-i.e., cortical-structure, despite the sparse presence of stress fibers (Fig. 6, lower panels) . A more complete depiction of this phenomenon is presented in Fig. 7 , in which control pituicytes display a dense alignment of stress fibers in resting conditions (i.e. with RhoA activated) versus a diffuse distribution of depolymerizing actin in the presence of adenosine (upper panels). Conversely, the actin of pituicytes expressing Cdc42-V12 retains a cortical localization following addition of adenosine Upper panels correspond to control conditions (GFP alone, no G14V). Based on a 1:10 concentration ratio cotransfection of GFP + mutant, bright cells in lower panels presumably reflect successful transfection of the mutant. Left: without adenosine; right: with 10 lM adenosine (ado). Notice two dim cells in lower right panel (arrowheads) that presumably fail to express G14V and therefore appear stellate. Scale bar: 50 lm (lower panels). As expected, adenosine-mediated stellation is prevented solely in those cells that express the Cdc42 mutant (lower right panel). Note that cortical actin also prevails a short time after exposure of stellate wild-type pituicytes to VP (inset), which has been shown to activate Cdc42 (Rosso et al. 2002b) .
As Rac1 is known to be implicated in cell morphology (Hall 1998) , we investigated its potential role in pituicyte stellation using constitutively active (V12) or dominant negative (N17) mutants of the GTPase. Neither V12-nor N17-Rac1 transduction had any effect on either ''resting'' pituicytes, which remained spread, or adenosinestimulated cells, which became stellate in the presence of the purine (Fig. 8) . On the other hand, a consistent finding was that adenosine-stimulated, stellate pituicytes expressing Rac1-V12 are larger and exhibit more numerous, long and branched processes than control cells (Fig. 8, top panel) . Fig. 5 Effects of phosphorylation-resistant (S188A) or phosphomimetic (S188D) RhoA mutant transfection (same method as in Fig. 4 ) on pituicyte morphology. Left image: S188A alone; middle image: S188A + 10 lM adenosine; note that not all cells are stellate consistent with the fact that adenosine never induces 100% stellation; right image: S188D alone. Scale bar: 50 lm Fig. 6 Effects of expression of a V12 constitutively active mutant of Cdc42 on adenosine-mediated pituicyte stellation. All pictures are in the presence of 10 lM adenosine. Actin is labeled with rhodamine-conjugated phalloidin (red). Upper row shows cells expressing GFP (green) alone (no V12); lower row shows cells expressing Cdc42-V12 protein fused to GFP. Notice two stellate, GFP-negative cells (arrowheads). Scale bar: 50 lm
Pituicyte Stellation and the Actin Cytoskeleton
Given the fact that RhoA or Cdc42 activation appears to block stellation in association with specific states of actin polymerization, we hypothesized that actin depolymerization might be a sufficient factor for pituicyte stellation. Similar to a previous study using cytochalasin B (Miyata et al. 1999) , we found that actin depolymerization by cytochalasin D indeed was a powerful means of inducing pituicyte stellation, with results consistently near 100% efficiency (Fig. 9, lower left panel) . Conversely, pituicyte incubation with increasing concentrations of jasplakinolide (JPK), a cell-permeant drug that stabilizes F-actin, provided proportionally increasing, i.e., dose-dependent, resistance to adenosine-mediated stellation up to almost complete blockade (Fig. 9) . At high concentrations (1-5 lM), JPK induced shape changes somehow resembling stellation, though treated cultures consisted more of both net-like structures with shriveling, dark somas and rounded, phase-bright but processless cells. As these effects might be nonspecific, they were not further investigated.
Next, to test, whether cortical actin organization was a sufficient condition to prevent stellation, we treated pituicytes with calyculin-A, a phosphatase inhibitor that dissolves stress fibers and induces cortical actin redistribution (Kreienbü hl et al. 1992; Patterson et al. 1999) . A striking result of that treatment was the rounding up of pituicytes along with a tendency to form aggregates, an effect consistently observed in various cell types (e.g. Patterson et al. 1999) . It is unlikely that cell rounding was the result of a non-specific, toxic effect of calyculin-A since (1) we used a concentration Fig. 7 Effects of Cdc42 activation on pituicyte actin cytoskeleton. Upper two pictures and inset represent wild-type pituicytes in 0.025%-serum medium, which maintains basal RhoA activation and dense actin (red) stress fibers in control conditions, and allows stellation in the presence of 10 lM adenosine. Inset displays initiation of stellation reversal by 10 nM VP applied for 3 min. Lower pictures are overlays of actin (red) and GFP+Cdc42-V12 (green) fluorescence. Left image: two V12+ cells (center) have lost most of their stress fibers and instead display cortical actin. Right image: V12-negative cells (arrowheads) are stellate in the presence of 10 lM adenosine, while V12+ cells are not. Notice the even more pronounced cortical localization of actin (yellow overlay) in that case. Scale bar: 60 lm ~20 times lower than that used in most studies, and (2) we did not observe any tendency of treated cells to detach from substrate. Following addition of adenosine, pituicytes remained rounded but no processes were formed, i.e., stellation was inhibited by calyculin-A (Fig. 9, upper right panel) . Finally, we verified that the actin cytoskeleton of JPK-or calyculin-A-treated cells was as predicted. Figure 10 shows that pituicytes incubated with 250 nM JPK or 5 nM calyculin-A display an actin cytoskeleton organized respectively as a stress-fiber or cortical network, both before and after addition of 10 lM adenosine. 
Discussion
Our siRNA experiments resulted in significant yet incomplete inhibition of RhoA and Cdc42. This is shown by the results of both our western blot and morphological analyses. In particular, if RhoA silencing was equivalent to its pharmacological inhibition, we would have expected a much higher level of stellation, which generally averages 70-80% in the presence of adenosine (e.g., Figs. 8 and 9 ). In addition to incomplete silencing, the fact that our knock-downs were performed in 10% serum suggests that remaining RhoA was in a fully activated form, making it difficult to disrupt stress fibers. Nevertheless, the fact that Cdc42 silencing results in significant stellation prompted us to test whether the GTPase might act downstream of RhoA, and this hypothesis is now strengthened by the observed increase in activity of Cdc42 in serum conditions that stimulate RhoA. In that perspective however, a difficulty arises as to the fact that each GTPase has widely different effects on the actin cytoskeleton, as discussed below. These conflicting notions might be resolved by hypothesizing that RhoA activates Cdc42 in parallel with an effector (such as p160Rho-kinase) that induces and maintains actin stress fibers in a dominant fashion. Thus, inhibiting RhoA would release pituicytes from cytoskeletal constraints that derive from both Cdc42 and the stress fiber-inducing effector, thereby triggering stellation. However, to comprehensively account for our results, alternative and perhaps more subtle forms of crosstalk between the two GTPases cannot be excluded.
Relevant to adenosine-induced pituicyte stellation, protein kinase A phosphorylation of a Ser residue has been suggested as one mechanism for RhoA inhibition (Lang et al. 1996; Ellerbroek et al. 2003 ). This indeed might represent an intriguing link between metabotropic receptor stimulation and monomeric GTPase inhibition. Given our results with phosphorylation-resistant and phosphomimetic mutants, however, this pathway can be ruled out regarding adenosine-mediated RhoA inhibition and ensuing stellation. In fact, our results are not surprising considering the following points. Ser phosphorylation of RhoA is normally related to its inhibition by a guanine-nucleotide dissociation inhibitor (GDI; Lang et al. 1996; Ellerbroek et al. 2003) . In this case, GTP-bound RhoA is not amenable to pull-down analysis (Ellerbroek et al. 2003) , which is inconsistent with our previous pull-down data (Rosso et al. 2002a) . RhoA inhibition by a GTPaseactivating protein (GAP) in turn can be measured by pull-down (Ellerbroek et al. 2003) . Furthermore, as RhoA-G14V, which is protected from GAP-mediated GTP hydrolysis, is an efficient stellation inhibitor in our hands, we believe that a GAP-related mechanism is more likely to mediate RhoA inhibition by adenosine. Not inconsistent with such a mechanism, Harrington et al. (2004) proposed that adenosine downregulates RhoA by decreasing its methylation state via inhibition of S-adenosylmethionine (SAM)-dependent methyltransferases. In order to rule out such non-receptor-mediated effects of adenosine, stellation experiments in the presence of nucleoside transport inhibitors will have to be performed.
Our previous studies suggested that actin stress fibers were responsible for pituicyte spreading and that their breakdown was the triggering event for stellation (Rosso et al. 2002a ). This view is no longer consistent with the observation that Cdc42 activation prevents stellation and maintains spreading while inhibiting stress fibers (Figs. 6 and 7) . We believe that the key observation to account for these effects is that Cdc42 does not simply inhibit stress fibers but also appears to reorganize polymerized actin in a cortical fashion, which is consistent with its reported induction of actin polymerization at the cell periphery (Gasman et al. 2004 ). In fact, a similar phenomenon can be observed when pituicytes are exposed to VP (inset of Fig. 7) , which, as we found, activates Cdc42 and reverses stellation (Rosso et al. 2002b) . Consistent with these data, pituicyte stellation is completely blocked by calyculin-A, an agent that dissolves stress fibers and induces cortical actin redistribution (Kreienbü hl et al. 1992; Patterson et al. 1999) . Incidentally, it would be interesting to investigate, e.g. by pull-down analysis, whether calyculin-A directly activates Cdc42. In that respect, it is worth mentioning previous work by others (Feoktistov et al. 2000) showing that calyculin-A potentiates cAMP-mediated activation of Cdc42.
From the above considerations, we could conclude that depolymerized actin, which might represent a default state in the absence of monomeric GTPase activity, constitutes a necessary and sufficient factor to induce stellation. Indeed, cytochalasin D is a very-if not the most-efficient agent for triggering pituicyte stellation. Conversely, our experiments with JPK and calyculin-A indicate that actin polymerization constitutes a sufficient condition to prevent stellation. The molecular basis for such a phenomenon remains to be determined. Perhaps polymerized actin, whether organized as stress fibers or cortical ring, constitutes a physical or biochemical barrier for the microtubule extensions that characterize stellation (Rosso et al. 2002a ). Contrary to the clear involvement of RhoA and Cdc42, our data suggest that in pituicytes Rac1 may not exert much effect upon actin as neither its constitutively active nor its dominant negative forms prevent or induce stellation. Intriguingly, in place of its known induction of lamellipodia and membrane ruffles (Hall 1998 ), Rac1 appears to have a distinct dendritogenic effect in pituicytes.
From a physiological viewpoint, our results with pituicytes may open a relevant avenue of investigation into the mechanisms that regulate the plasticity of other astrocytes of the nervous system in vivo.
